Zhang, C. (2020) “Connecting asciminib tolerability to long-term treatment persistence. Comment on: "Favorable tolerability of asciminib versus ATP-competitive tyrosine kinase inhibitors in the ASC4FIRST study of newly diagnosed patients with chronic-phase chronic myeloid leukemia"”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301608.